FindTrial
Sign In

The role of m6A related genes in prognosis and immune microenvironment of early lung adenocarcinoma

The role of m6A related genes in prognosis and immune microenvironment of early lung adenocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050244
Enrollment
Unknown
Registered
2021-08-24
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung adenocarcinoma

Interventions

case group:Nil

Sponsors

People's Hospital of Deyang City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The first diagnosis was early lung adenocarcinoma, which was confirmed by pathological examination; 2. No other autoimmune diseases; 3. Aged from 18 to 70 years.

Exclusion criteria

Exclusion criteria: 1. Complicated with other malignant tumors; 2. Preoperative adjuvant chemotherapy, radiotherapy or targeted therapy; 3. Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
M6A related gene indicators;—

Countries

China

Contacts

Public ContactHe Miao

People's Hospital of Deyang City

18090022113@163.com+86 18090022113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026